NMRbox: Bayesian Analytics
NMRbox:贝叶斯分析
基本信息
- 批准号:10652475
- 负责人:
- 金额:$ 14.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-09-01 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdvanced DevelopmentAreaAutomationBayes TheoremBayesian AnalysisBayesian MethodBiologicalBiomolecular Nuclear Magnetic ResonanceCellsCollaborationsCommunicationCommunitiesComplementComputer AnalysisComputer softwareComputing MethodologiesDataData AnalysesData AnalyticsDepositionDevelopmentDiagnosticEcosystemEnsureEvaluationExperimental ModelsFutureGoalsHealth StatusHourIntelligenceInvestigationKnowledgeLeadLibrariesLocationMass Spectrum AnalysisMetabolicModelingMolecularMolecular ProfilingNMR SpectroscopyPharmaceutical PreparationsProbabilityProceduresProcessProteinsRelaxationReliability of ResultsReproducibilityResearch PersonnelResource DevelopmentResourcesSamplingScienceShapesSourceSpecific qualifier valueStatistical ModelsTechnologyTechnology AssessmentTranslationsValidationVisualVisualization softwareWorkanalytical methodcommunity engagementcomputational platformcomputer frameworkcomputerized data processingdata exchangedata formatdata modelingdesignflexibilityheterogenous dataimprovedinstrumentmathematical methodsmetabolomicspreservationsignature moleculesmall moleculesupport toolstoolvirtual machine
项目摘要
Abstract: TRD 3. Nuclear magnetic resonance spectroscopy (NMR) is a powerful analytical
instrument with numerous applications in biomedicine. Some examples of high-impact
investigation are studies using metabolite profiles as markers of health status, evaluation of
small molecules for biological activity as a drug, and discovery of new metabolic compounds.
NMR offers detailed information, but the interpretation of data involves a multistep process that
often involves using data from other analytical instruments. The use of a range of sophisticated
mathematical and computational methods is required, and this is often a major bottleneck. The
aim of this TRD is to deliver enhanced functionality for robust and reliable statistical framework,
based on Bayesian principles. This project will advance the state of NMR data analytics and
simplifies the future development of advanced NMR applications. Central components of this
TRD include a Bayesian inference engine, tools for validation of experimental models and
results, a set of programming interfaces, and a library of templates for facilitating the
identification of metabolite and small molecule signatures in biological mixtures. The
implementation of this TRD will benefit from key advantages offered by the NMRbox platform.
By facilitating the deployment, utilization, interoperation, and persistence of this advanced
technology, the proposed TRD will advance the application of NMR for a wide range of
challenging applications in biomedicine and helps ensure the reproducibility bio-NMR studies.
翻译后摘要:TRD 3。核磁共振光谱(NMR)是一种强有力的分析方法,
在生物医学中有许多应用的仪器。高影响力的一些例子
调查是使用代谢物谱作为健康状况标志物的研究,
小分子作为药物的生物活性,以及发现新的代谢化合物。
核磁共振提供了详细的信息,但数据的解释涉及一个多步骤的过程,
通常涉及使用来自其他分析仪器的数据。使用一系列复杂的
需要数学和计算方法,这往往是一个主要的瓶颈。的
该TRD的目的是为强大和可靠的统计框架提供增强的功能,
基于贝叶斯原理。该项目将推进NMR数据分析的发展,
简化了先进NMR应用的未来发展。核心组成部分,
TRD包括一个贝叶斯推理引擎,用于验证实验模型的工具,
结果、一组编程接口和一个模板库,
生物混合物中代谢物和小分子特征鉴定。的
该TRD的实施将受益于NMRbox平台提供的关键优势。
通过促进这种高级的
技术,拟议的TRD将推进NMR在广泛领域的应用,
在生物医学中具有挑战性的应用,并有助于确保生物NMR研究的重现性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HAMID R EGHBALNIA其他文献
HAMID R EGHBALNIA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HAMID R EGHBALNIA', 18)}}的其他基金
Informatics/modeling/extend/NMR structure determination
信息学/建模/扩展/NMR结构测定
- 批准号:
7021075 - 财政年份:2006
- 资助金额:
$ 14.11万 - 项目类别:
Informatics/modeling/extend/NMR structure determination
信息学/建模/扩展/NMR结构测定
- 批准号:
7359619 - 财政年份:2006
- 资助金额:
$ 14.11万 - 项目类别:
Informatics/modeling/extend/NMR structure determination
信息学/建模/扩展/NMR结构测定
- 批准号:
7755643 - 财政年份:2006
- 资助金额:
$ 14.11万 - 项目类别:
Informatics/modeling/extend/NMR structure determination
信息学/建模/扩展/NMR结构测定
- 批准号:
7186620 - 财政年份:2006
- 资助金额:
$ 14.11万 - 项目类别:
相似海外基金
ADVANCED DEVELOPMENT OF LQ A LIPOSOME-BASED SAPONIN-CONTAINING ADJUVANT FOR USE IN PANSARBECOVIRUS VACCINES
用于 Pansarbecovirus 疫苗的 LQ A 脂质体含皂苷佐剂的先进开发
- 批准号:
10935820 - 财政年份:2023
- 资助金额:
$ 14.11万 - 项目类别:
ADVANCED DEVELOPMENT OF BBT-059 AS A RADIATION MEDICAL COUNTERMEASURE FOR DOSING UP TO 48H POST EXPOSURE"
BBT-059 的先进开发,作为辐射医学对策,可在暴露后 48 小时内进行给药”
- 批准号:
10932514 - 财政年份:2023
- 资助金额:
$ 14.11万 - 项目类别:
Advanced Development of a Combined Shigella-ETEC Vaccine
志贺氏菌-ETEC 联合疫苗的先进开发
- 批准号:
10704845 - 财政年份:2023
- 资助金额:
$ 14.11万 - 项目类别:
Advanced development of composite gene delivery and CAR engineering systems
复合基因递送和CAR工程系统的先进开发
- 批准号:
10709085 - 财政年份:2023
- 资助金额:
$ 14.11万 - 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
- 批准号:
10409385 - 财政年份:2022
- 资助金额:
$ 14.11万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
- 批准号:
10710595 - 财政年份:2022
- 资助金额:
$ 14.11万 - 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
- 批准号:
10630975 - 财政年份:2022
- 资助金额:
$ 14.11万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE CANDIDATE FOR STAPHYLOCOCCUS AUREUS INFECTION
金黄色葡萄球菌感染候选疫苗的高级开发
- 批准号:
10710588 - 财政年份:2022
- 资助金额:
$ 14.11万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
- 批准号:
10788051 - 财政年份:2022
- 资助金额:
$ 14.11万 - 项目类别:














{{item.name}}会员




